市场调查报告书
商品编码
1451538
2024-2032 年按产品、最终用户和地区分類的神经科设备市场报告Neurology Devices Market Report by Product, End User, and Region 2024-2032 |
2023年全球神经科设备市场规模达134亿美元。展望未来, IMARC Group预计到2032年市场规模将达到251亿美元,2024-2032年复合年增长率(CAGR)为7.1%。
神经病学是一门研究神经系统疾病和失调的医学科学。神经病学中广泛使用的设备有多种类型。例如,骶神经刺激装置透过向位于下背部的目标骶神经发送电脉衝来发挥作用。另一方面,脑脊髓液管理装置维持脑脊髓液流动并排出大脑中多余的液体。据此,介入设备使用放射学和导管来诊断中枢神经系统中存在的医疗状况,而深部脑刺激设备则透过植入向大脑中特定目标区域发送电脉衝的医疗设备来帮助执行手术。这些设备有助于治疗复杂的疾病。因此,它们广泛应用于治疗许多神经系统疾病,如强迫症、帕金森氏症、肌张力失调、慢性疼痛、特发性震颤和重度忧郁症。
该市场主要由医疗保健行业的大幅成长所推动。除此之外,全球范围内神经系统疾病的日益普及也大大增加了产品需求。老年人口的增加和老年人中风等神经血管疾病发病率的上升进一步推动了神经科设备的采用,从而促进了市场的成长。此外,神经病学设备的持续技术进步和对微创(MI)手术的广泛需求也是全球范围内重要的成长诱导因素。推动市场成长的其他一些因素包括不断扩大的医疗保健支出、全球医疗器材製造商的巨额投资以及神经治疗领域的广泛研发(R&D)。
The global neurology devices market size reached US$ 13.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.1 Billion by 2032, exhibiting a growth rate (CAGR) of 7.1% during 2024-2032.
Neurology is a stream of medical science that deals with diseases and disorders of the nervous system. There are numerous types of devices that are widely used in neurology. For instance, sacral nerve stimulation devices function by sending electrical impulses to the targeted sacral nerves located in the lower back. On the other hand, cerebrospinal fluid management devices maintain the cerebrospinal fluid flow and drain excess fluid from the brain. In line with this, interventional devices use radiology and catheters to diagnose the medical conditions present in the central nervous system, whereas deep brain stimulation devices aid in performing procedures by implanting a medical device that sends electrical impulses to specific target areas in the brain. These devices are instrumental in treating complex disorders. As a result, they find widespread applications in the treatment of numerous neurological disorders, such as obsessive-compulsive disorder, Parkinson's disease, dystonia, chronic pain, essential tremor, and major depression.
The market is primarily driven by considerable growth in the healthcare sector. In addition to this, the growing prevalence of neurological disorders across the globe is significantly contributing to the product demand. The increasing geriatric population and the rising incidences of neurovascular conditions, such as stroke, among the elderly are further propelling the adoption of neurology devices, thereby augmenting the growth of the market. Moreover, continual technological advancements in neurology devices and the widespread demand for minimally invasive (MI) surgeries are also acting as significant growth-inducing factors across the globe. Some of the other factors providing an impetus to the market growth include the expanding healthcare expenditure, huge investments made by global medical device manufacturers and extensive research and development (R&D) in the field of neurotherapy.
IMARC Group provides an analysis of the key trends in each sub-segment of the global neurology devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and end user.
Neurostimulation Devices
Neurosurgery Devices
Interventional Neurology Devices
Cerebrospinal Fluid Management Devices
Others
Hospitals
Ambulatory Surgery Centers
Neurology Clinics
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun, Boston Scientific Corporation, Integra LifeSciences, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Penumbra Inc. and Stryker Corporation.